局部晚期-话题@MedSci

#局部晚期#

176篇内容 | 3314人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1650728, encodeId=fbd81650e28d2, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？, objectType=article, longId=124124, objectId=0703124124e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0703124124e3, replyNumber=0, likeNumber=74, createdTime=2018-06-25, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0703124124e3, moduleTitle=J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0703124124e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650727, encodeId=c3f51650e2712, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA SURGERY：新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌, objectType=article, longId=121890, objectId=32f8121890c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f8121890c2, replyNumber=0, likeNumber=85, createdTime=2018-02-25, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f8121890c2, moduleTitle=JAMA SURGERY：新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f8121890c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650730, encodeId=541c1650e3091, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA Surg：局部晚期膀胱癌：RC后辅助三明治化疗+放疗vs仅辅助化疗, objectType=article, longId=124706, objectId=8f9b124e06e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f9b124e06e0, replyNumber=0, likeNumber=90, createdTime=2018-11-02, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f9b124e06e0, moduleTitle=JAMA Surg：局部晚期膀胱癌：RC后辅助三明治化疗+放疗vs仅辅助化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f9b124e06e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650719, encodeId=57fd1650e191c, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J CLIN ONCOL:放射治疗后的心脏事件：对局部晚期非小细胞肺癌的前瞻性多中心试验综合分析, objectType=article, longId=100990, objectId=c91b10099052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c91b10099052, replyNumber=0, likeNumber=59, createdTime=2018-01-04, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c91b10099052, moduleTitle=J CLIN ONCOL:放射治疗后的心脏事件：对局部晚期非小细胞肺癌的前瞻性多中心试验综合分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c91b10099052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650720, encodeId=388c1650e2007, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA Oncol：PET / CT用于局部晚期非小细胞肺癌患者, objectType=article, longId=102443, objectId=b69810244381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b69810244381, replyNumber=0, likeNumber=48, createdTime=2018-05-19, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b69810244381, moduleTitle=JAMA Oncol：PET / CT用于局部晚期非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b69810244381)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650723, encodeId=4c281650e23b8, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA Oncol： Durvalumab在局部晚期或转移性尿路上皮癌中疗效如何？, objectType=article, longId=110698, objectId=81a911069830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81a911069830, replyNumber=0, likeNumber=61, createdTime=2018-07-05, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81a911069830, moduleTitle=JAMA Oncol： Durvalumab在局部晚期或转移性尿路上皮癌中疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81a911069830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650732, encodeId=7ccc1650e32f6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JCO：局部晚期NSCLC，质子和光子放疗，谁主沉浮？, objectType=article, longId=125863, objectId=932d12586384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=932d12586384, replyNumber=0, likeNumber=81, createdTime=2018-09-17, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=932d12586384, moduleTitle=JCO：局部晚期NSCLC，质子和光子放疗，谁主沉浮？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=932d12586384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650729, encodeId=1e4c1650e29b3, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J Clin Oncol：局部晚期NSCLC术后应该先放疗还是先化疗？, objectType=article, longId=124510, objectId=cecc1245109f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cecc1245109f, replyNumber=0, likeNumber=75, createdTime=2018-10-28, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cecc1245109f, moduleTitle=J Clin Oncol：局部晚期NSCLC术后应该先放疗还是先化疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cecc1245109f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650725, encodeId=333d1650e25a5, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JCO：Dabrafenib和Trametinib治疗局部晚期或转移性BRAFV600突变甲状腺未分化癌, objectType=article, longId=118188, objectId=f3d911818880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3d911818880, replyNumber=0, likeNumber=80, createdTime=2017-11-02, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3d911818880, moduleTitle=JCO：Dabrafenib和Trametinib治疗局部晚期或转移性BRAFV600突变甲状腺未分化癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3d911818880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650721, encodeId=67191650e21d6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA SURGERY：局部晚期直肠癌患者未完成新辅助放疗与生存的关系, objectType=article, longId=105044, objectId=36191050444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36191050444e, replyNumber=0, likeNumber=60, createdTime=2018-03-07, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36191050444e, moduleTitle=JAMA SURGERY：局部晚期直肠癌患者未完成新辅助放疗与生存的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36191050444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650731, encodeId=3b671650e3121, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=EUR J Cancer：舒尼替尼治疗局部晚期或转移性、间变性甲状腺髓质癌的多中心II期临床试验, objectType=article, longId=124996, objectId=11e112499612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e112499612, replyNumber=0, likeNumber=56, createdTime=2018-11-20, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e112499612, moduleTitle=EUR J Cancer：舒尼替尼治疗局部晚期或转移性、间变性甲状腺髓质癌的多中心II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e112499612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650722, encodeId=a56d1650e223a, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Ann Oncol：局部晚期头颈部鳞状细胞癌的HPV状态是否能决定其有效化疗方案（EORTC 24971研究的亚组分析）, objectType=article, longId=106824, objectId=70fc106824cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70fc106824cf, replyNumber=0, likeNumber=88, createdTime=2018-01-10, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70fc106824cf, moduleTitle=Ann Oncol：局部晚期头颈部鳞状细胞癌的HPV状态是否能决定其有效化疗方案（EORTC 24971研究的亚组分析）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70fc106824cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650717, encodeId=24a51650e1754, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J Clin Oncol：局部晚期非小细胞肺癌：强度调控放疗vs三维适形体外放疗, objectType=article, longId=95712, objectId=799f95e1281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=799f95e1281, replyNumber=0, likeNumber=63, createdTime=2018-03-22, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=799f95e1281, moduleTitle=J Clin Oncol：局部晚期非小细胞肺癌：强度调控放疗vs三维适形体外放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=799f95e1281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650715, encodeId=bbdf1650e1585, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=lancet oncol：派姆单抗（pembrolizumab）在局部晚期或转移性尿路上皮癌患者中安全性和活性的1期临床研究(KEYNOTE-012), objectType=article, longId=87698, objectId=f06c8e69880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06c8e69880, replyNumber=0, likeNumber=61, createdTime=2017-03-10, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06c8e69880, moduleTitle=lancet oncol：派姆单抗（pembrolizumab）在局部晚期或转移性尿路上皮癌患者中安全性和活性的1期临床研究(KEYNOTE-012), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f06c8e69880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650716, encodeId=68d71650e160b, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=The Lancet Oncology：Avelumab用于转移性或局部晚期实体瘤, objectType=article, longId=94245, objectId=80ff942459a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80ff942459a, replyNumber=0, likeNumber=55, createdTime=2017-05-14, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80ff942459a, moduleTitle=The Lancet Oncology：Avelumab用于转移性或局部晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80ff942459a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650718, encodeId=f8141650e18c7, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JCO：你知道哪种化疗方案对局部晚期鼻咽癌患者更有效吗？, objectType=article, longId=99687, objectId=38e19968ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38e19968ea2, replyNumber=0, likeNumber=80, createdTime=2017-11-15, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38e19968ea2, moduleTitle=JCO：你知道哪种化疗方案对局部晚期鼻咽癌患者更有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38e19968ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650714, encodeId=94d21650e147f, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=2016NICE技术评估指南：osimertinib用于治疗局部晚期或转移性EGFR T790M突变阳性非小细胞肺癌（TA416）发布, objectType=article, longId=81116, objectId=25a48111657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25a48111657, replyNumber=0, likeNumber=33, createdTime=2017-08-23, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25a48111657, moduleTitle=2016NICE技术评估指南：osimertinib用于治疗局部晚期或转移性EGFR T790M突变阳性非小细胞肺癌（TA416）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25a48111657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650713, encodeId=27471650e132e, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=ESMO 2016：新辅助放化疗可延长局部晚期食管鳞状细胞癌患者的生存期, objectType=article, longId=79647, objectId=cd0be96471b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd0be96471b, replyNumber=0, likeNumber=72, createdTime=2017-04-27, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd0be96471b, moduleTitle=ESMO 2016：新辅助放化疗可延长局部晚期食管鳞状细胞癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd0be96471b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650712, encodeId=47491650e123c, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=局部晚期直肠癌：改良 FOLFOX6 方案可供参考, objectType=article, longId=77194, objectId=1021e71948c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1021e71948c, replyNumber=0, likeNumber=69, createdTime=2017-06-09, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1021e71948c, moduleTitle=局部晚期直肠癌：改良 FOLFOX6 方案可供参考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1021e71948c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650711, encodeId=481d1650e117c, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=ASCO：局部晚期不可切除胰腺癌临床实践指南, objectType=article, longId=73612, objectId=bb5de3612da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb5de3612da, replyNumber=0, likeNumber=56, createdTime=2017-04-28, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb5de3612da, moduleTitle=ASCO：局部晚期不可切除胰腺癌临床实践指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb5de3612da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部晚期

2020-05-29

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？

2018-06-25

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA SURGERY：新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌

2018-02-25

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA Surg：局部晚期膀胱癌：RC后辅助三明治化疗+放疗vs仅辅助化疗

2018-11-02

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J CLIN ONCOL:放射治疗后的心脏事件：对局部晚期非小细胞肺癌的前瞻性多中心试验综合分析

2018-01-04

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA Oncol：PET / CT用于局部晚期非小细胞肺癌患者

2018-05-19

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA Oncol： Durvalumab在局部晚期或转移性尿路上皮癌中疗效如何？

2018-07-05

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JCO：局部晚期NSCLC，质子和光子放疗，谁主沉浮？

2018-09-17

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J Clin Oncol：局部晚期NSCLC术后应该先放疗还是先化疗？

2018-10-28

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JCO：Dabrafenib和Trametinib治疗局部晚期或转移性BRAFV600突变甲状腺未分化癌

2017-11-02

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA SURGERY：局部晚期直肠癌患者未完成新辅助放疗与生存的关系

2018-03-07

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

EUR J Cancer：舒尼替尼治疗局部晚期或转移性、间变性甲状腺髓质癌的多中心II期临床试验

2018-11-20

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Ann Oncol：局部晚期头颈部鳞状细胞癌的HPV状态是否能决定其有效化疗方案（EORTC 24971研究的亚组分析）

2018-01-10

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J Clin Oncol：局部晚期非小细胞肺癌：强度调控放疗vs三维适形体外放疗

2018-03-22

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

lancet oncol：派姆单抗（pembrolizumab）在局部晚期或转移性尿路上皮癌患者中安全性和活性的1期临床研究(KEYNOTE-012)

2017-03-10

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

The Lancet Oncology：Avelumab用于转移性或局部晚期实体瘤

2017-05-14

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JCO：你知道哪种化疗方案对局部晚期鼻咽癌患者更有效吗？

2017-11-15

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

2016NICE技术评估指南：osimertinib用于治疗局部晚期或转移性EGFR T790M突变阳性非小细胞肺癌（TA416）发布

2017-08-23

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

ESMO 2016：新辅助放化疗可延长局部晚期食管鳞状细胞癌患者的生存期

2017-04-27

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

局部晚期直肠癌：改良 FOLFOX6 方案可供参考

2017-06-09

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

ASCO：局部晚期不可切除胰腺癌临床实践指南

2017-04-28

科室
- - 订阅+
  - 更多科室
工具
服务